Table 1.
Period | Country | Number of CDB casesa | Incidence | Reference |
---|---|---|---|---|
1962–1969 | USA | 3 Isolates/86 nonhistotoxic clostridial bacteremias (laboratory isolates)* | 0.4 | [42], [52] |
15 months | USA | 1 Blood culture isolate (Anaerobe study)* | 0.8 | [53] |
14 months | USA | 1 CDB/2168 bacteremias* | 0.9 | [30] |
1985–1995 | USA | 3 CDB/14 ECD2 | 0.3 | [31] |
1990–1997 | USA | 1/164 304 hospitalizations* | 0.13 | [32] |
1990–2000 | Spain | 2 CDB/21 ECD (50 000 admissions/year)b | 0.2 | [33] |
1988–2003 | USA | 2 Blood culture isolates/25 ECD* | 0.2 | [34] |
2000–2006 | Canada | 7 CDB/1.2 million residents* | 1 | [35] |
2004–2008 | UK | 62 CDB/320 371 bacteremias* | 9 to 17 | [36], [37] |
2008–2012 | UK | 0 | 0 | [38] |
2010–2014 | UK | 0 | 0 | [39] |
1989–2009 | Taiwan | 12 CDB/2 medical centersb,c | 0.6 | [43] |
2002–2012 | Finland | 2 CDB/31 ECDb | 0.2 | [54] |
2004–2013 | USA | 11 CDB/40 ECD/6525 CDIb | 1.1 | [28] |
1962–2016 | All countries | Total: 137 (the 58 published casesb, the two present casesb and 77* cases in other reports) | Present review |
CDB cases of each study or literature review when clearly mentioned in articles or reports.
Cases with clinical data reported in Table 2.
1100-bed and 2800-bed tertiary-care hospitals in Taiwan.
Cases not available with clinical data but exposed in other reports in the reviewed literature.